Observational studyEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2025
Cardiovascular risk and statin prescription in primary care: an observational study, São Leopoldo, 2018-2021.
Observational study in Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo present the cardiovascular risk strata based on the Global HEARTS Initiative calculator and analyze statin prescription among users of Primary Health Care in São Leopoldo, Rio Grande do Sul.
methodsThis was a cross-sectional observational study including users aged 18 years or older listed in the Cardiovascular Risk Operational Report. Categorical data were presented as absolute and relative frequencies and 95% confidence intervals (95%CI). Associations between categorical variables were analyzed using the chi-square test or Fisher's exact test, with statistical significance defined as p-value≤0.050.
resultsIt was possible to calculate the cardiovascular risk of 2,199 users. Most users presented low (41.4%; 95%CI 39.3; 43.5) or moderate risk (38.0%; 95%CI 36.0; 40.1), while 19.6% (95%CI 18.0; 21.3) had high risk and 1.0% (95%CI 0.6; 1.4) had very high risk. Statin prescription was recorded in 29.5% (95%CI 27.6; 31.4) of the medical records. There was a statistically significant association (p-value<0.001) between cardiovascular risk and statin prescription, with higher prescription frequency among high-risk users (41.2%).
conclusionMost Primary Health Care users in São Leopoldo had low to moderate cardiovascular risk. The prescription of statins was consistent with clinical guidelines, considering cardiovascular risk in decision-making; however, it was reached by less than one-third of the overall sample.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.